In vivo selection of H1N2 influenza virus reassortants in the ferret model.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3592131)

Published in J Virol on January 09, 2013

Authors

Matthew Angel1, J Brian Kimble, Lindomar Pena, Hongquan Wan, Daniel R Perez

Author Affiliations

1: Department of Veterinary Medicine, University of Maryland, College Park, MD, USA.

Articles cited by this

Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99

Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature (2009) 17.96

Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28

A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16

Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol (1989) 10.63

On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology (1978) 9.02

Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (2009) 7.80

Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A (2006) 6.35

Rates of spontaneous mutation among RNA viruses. Proc Natl Acad Sci U S A (1993) 5.42

Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci U S A (2009) 3.30

Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One (2008) 2.86

Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis (2011) 2.42

Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog (2008) 2.38

Reassortment between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment. J Virol (2009) 2.33

High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29

Lessons for human influenza from pathogenicity studies with ferrets. Rev Infect Dis (1988) 2.21

Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog (2011) 1.87

Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A (2012) 1.80

Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci U S A (2010) 1.56

Emergence of novel reassortant H3N2 swine influenza viruses with the 2009 pandemic H1N1 genes in the United States. Arch Virol (2011) 1.37

Novel reassortment of Eurasian avian-like and pandemic/2009 influenza viruses in swine: infectious potential for humans. J Virol (2011) 1.33

Possible increased pathogenicity of pandemic (H1N1) 2009 influenza virus upon reassortment. Emerg Infect Dis (2011) 1.31

Pathogenicity and transmission in pigs of the novel A(H3N2)v influenza virus isolated from humans and characterization of swine H3N2 viruses isolated in 2010-2011. J Virol (2012) 1.26

Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses. Proc Natl Acad Sci U S A (2011) 1.23

Serological characteristics of a "new" serotype of influenza A virus: the Hong Kong strain. Bull World Health Organ (1969) 1.21

Fitness of pandemic H1N1 and seasonal influenza A viruses during co-infection: evidence of competitive advantage of pandemic H1N1 influenza versus seasonal influenza. PLoS Curr (2009) 1.19

The neuraminidase and matrix genes of the 2009 pandemic influenza H1N1 virus cooperate functionally to facilitate efficient replication and transmissibility in pigs. J Gen Virol (2012) 1.02

Reassortment between seasonal H1N1 and pandemic (H1N1) 2009 influenza viruses is restricted by limited compatibility among polymerase subunits. J Virol (2011) 0.95

Reassortment between seasonal and swine-origin H1N1 influenza viruses generates viruses with enhanced growth capability in cell culture. Virus Res (2010) 0.93

AlleleID: a pathogen detection and identification system. Methods Mol Biol (2007) 0.82

Articles by these authors

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol (2009) 12.13

A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A (2008) 3.99

Gain-of-function experiments on H7N9. Science (2013) 3.67

Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 influenza A virus. Proc Natl Acad Sci U S A (2009) 3.30

The influenza virus gene pool in a poultry market in South central china. Virology (2003) 3.25

Characterization of H5N1 influenza viruses that continue to circulate in geese in southeastern China. J Virol (2002) 2.97

Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells. J Virol (2007) 2.89

Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS One (2008) 2.86

Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol (2008) 2.71

Novel reassortant highly pathogenic H5N2 avian influenza viruses in poultry in China. PLoS One (2012) 2.43

Avian flu: Gain-of-function experiments on H7N9. Nature (2013) 2.32

Pause on avian flu transmission research. Science (2012) 2.24

Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol (2010) 2.19

Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17

Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology (2005) 2.17

Pathogenesis of Hong Kong H5N1 influenza virus NS gene reassortants in mice: the role of cytokines and B- and T-cell responses. J Gen Virol (2005) 2.15

Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol (2006) 2.01

GM-CSF in the lung protects against lethal influenza infection. Am J Respir Crit Care Med (2011) 1.83

Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens. J Virol (2004) 1.83

Novel reassortant highly pathogenic avian influenza (H5N5) viruses in domestic ducks, China. Emerg Infect Dis (2011) 1.82

Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J Virol (2010) 1.81

Novel variants of clade 2.3.4 highly pathogenic avian influenza A(H5N1) viruses, China. Emerg Infect Dis (2013) 1.80

Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog (2010) 1.70

Replication and transmission of influenza viruses in Japanese quail. Virology (2003) 1.64

Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens. PLoS One (2008) 1.63

Neurovirulence in mice of H5N1 influenza virus genotypes isolated from Hong Kong poultry in 2001. J Virol (2003) 1.62

A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol (2007) 1.50

Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog (2011) 1.49

Deceptive imprinting and immune refocusing in vaccine design. Vaccine (2008) 1.47

Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections. J Immunol (2010) 1.38

Lack of LDL receptor aggravates learning deficits and amyloid deposits in Alzheimer transgenic mice. Neurobiol Aging (2005) 1.32

Avian influenza virus isolated in wild waterfowl in Argentina: evidence of a potentially unique phylogenetic lineage in South America. Virology (2008) 1.26

Preparation of a standardized, efficacious agricultural H5N3 vaccine by reverse genetics. Virology (2003) 1.24

Evidence of reassortment of pandemic H1N1 influenza virus in swine in Argentina: are we facing the expansion of potential epicenters of influenza emergence? Influenza Other Respir Viruses (2011) 1.21

Fitness of pandemic H1N1 and seasonal influenza A viruses during co-infection: evidence of competitive advantage of pandemic H1N1 influenza versus seasonal influenza. PLoS Curr (2009) 1.19

A 27-amino-acid deletion in the neuraminidase stalk supports replication of an avian H2N2 influenza A virus in the respiratory tract of chickens. J Virol (2010) 1.18

Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus. J Gen Virol (2010) 1.16

Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice. Virology (2012) 1.16

Influenza viruses with rearranged genomes as live-attenuated vaccines. J Virol (2013) 1.15

Characterization of influenza virus sialic acid receptors in minor poultry species. Virol J (2010) 1.13

Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses. J Virol (2010) 1.09

Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. J Virol (2009) 1.08

Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One (2009) 1.08

Amino acid 316 of hemagglutinin and the neuraminidase stalk length influence virulence of H9N2 influenza virus in chickens and mice. J Virol (2012) 1.08

Evidence for avian H9N2 influenza virus infections among rural villagers in Cambodia. J Infect Public Health (2013) 1.08

Transmission studies resume for avian flu. Science (2013) 1.07

Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice. PLoS One (2011) 1.06

Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice. PLoS One (2008) 1.04

Evidence for seasonal patterns in the relative abundance of avian influenza virus subtypes in blue-winged teal (Anas discors). J Wildl Dis (2014) 1.04

Outbreak of swine influenza in Argentina reveals a non-contemporary human H3N2 virus highly transmissible among pigs. J Gen Virol (2011) 1.04

Influenza a viruses from wild birds in Guatemala belong to the North American lineage. PLoS One (2012) 1.02

Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses. J Virol (2013) 1.02

Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol Med Microbiol (2008) 1.01

Phylogenetic analysis of H6 influenza viruses isolated from rosy-billed pochards (Netta peposaca) in Argentina reveals the presence of different HA gene clusters. J Virol (2011) 1.01

Characterization of duck H5N1 influenza viruses with differing pathogenicity in mallard (Anas platyrhynchos) ducks. Avian Pathol (2009) 0.98

Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v. J Virol (2013) 0.97

Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity. Virol J (2009) 0.97

An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines. J Gen Virol (2008) 0.97

Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in mice. Clin Vaccine Immunol (2010) 0.96

Restored PB1-F2 in the 2009 pandemic H1N1 influenza virus has minimal effects in swine. J Virol (2012) 0.94

Receptor characterization and susceptibility of cotton rats to avian and 2009 pandemic influenza virus strains. J Virol (2012) 0.94

Alternative reassortment events leading to transmissible H9N1 influenza viruses in the ferret model. J Virol (2013) 0.91

Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol (2015) 0.90

Strain-dependent effects of PB1-F2 of triple-reassortant H3N2 influenza viruses in swine. J Gen Virol (2012) 0.89

Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. Vaccine (2011) 0.87

Heightened adaptive immune responses following vaccination with a temperature-sensitive, live-attenuated influenza virus compared to adjuvanted, whole-inactivated virus in pigs. Vaccine (2012) 0.87

Artificial recombination may influence the evolutionary analysis of Newcastle disease virus. J Virol (2011) 0.86

Where do avian influenza viruses meet in the Americas? Avian Dis (2012) 0.85

Immunosenescence and age-related susceptibility to influenza virus in Japanese quail. Dev Comp Immunol (2006) 0.85

Isolation and characterization of an H9N2 influenza virus isolated in Argentina. Virus Res (2012) 0.84

Partial and full PCR-based reverse genetics strategy for influenza viruses. PLoS One (2012) 0.81

Deletions in the neuraminidase stalk region of H2N2 and H9N2 avian influenza virus subtypes do not affect postinfluenza secondary bacterial pneumonia. J Virol (2012) 0.81

A novel monoclonal antibody effective against lethal challenge with swine-lineage and 2009 pandemic H1N1 influenza viruses in mice. Virology (2011) 0.81

Antigenic mapping of the hemagglutinin of an H9N2 avian influenza virus reveals novel critical amino acid positions in antigenic sites. J Virol (2014) 0.81

Swine influenza virus vaccine serologic cross-reactivity to contemporary US swine H3N2 and efficacy in pigs infected with an H3N2 similar to 2011-2012 H3N2v. Influenza Other Respir Viruses (2013) 0.80

Adaptation of a mallard H5N2 low pathogenicity influenza virus in chickens with prior history of infection with infectious bursal disease virus. Avian Dis (2010) 0.78

Passive immune neutralization strategies for prevention and control of influenza A infections. Immunotherapy (2012) 0.78

Design of alternative live attenuated influenza virus vaccines. Curr Top Microbiol Immunol (2015) 0.77

Rapid detection of duck hepatitis virus type-1 by reverse transcription loop-mediated isothermal amplification. J Virol Methods (2012) 0.77

Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses. Virol J (2011) 0.76

An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer. J Hum Genet (2015) 0.75

A monoclonal antibody-based ELISA for differential diagnosis of 2009 pandemic H1N1. Influenza Other Respir Viruses (2011) 0.75